{"gene":"POLB","run_date":"2026-06-10T06:43:35","timeline":{"discoveries":[{"year":2012,"finding":"POLB variants found in 40% of colorectal tumors show reduced polymerase activity in vitro and fail to fully rescue POLB-deficient cells from methylmethane sulfonate (MMS)-induced cytotoxicity, demonstrating that loss-of-function POLB mutations compromise base excision repair (BER) and may drive genomic instability.","method":"In vitro polymerase activity assays of tumor-derived POLB variants; MMS cytotoxicity rescue assay in pol β-deficient cells","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro enzymatic activity assays plus cell-based rescue experiments in a single lab with two orthogonal methods","pmids":["22577134"],"is_preprint":false},{"year":2014,"finding":"Mice expressing a hypomorphic POLB allele encoding a slow-activity pol β (Y265C) develop lupus-like autoimmune disease with shorter immunoglobulin heavy-chain junctions and dramatically increased somatic hypermutation, establishing that decreased pol β catalytic activity during generation of immune diversity leads to aberrant BER intermediates that drive autoimmunity.","method":"Knock-in mouse model expressing hypomorphic POLB-Y265C allele; analysis of antinuclear antibodies, glomerulonephritis, immunoglobulin junction lengths, and somatic hypermutation rates","journal":"Cell reports","confidence":"High","confidence_rationale":"Tier 2 / Strong — in vivo genetic mouse model with multiple orthogonal phenotypic readouts (immunology, pathology, molecular) establishing mechanistic link between pol β activity and immune repertoire generation","pmids":["24388753"],"is_preprint":false},{"year":2017,"finding":"POLB (DNA polymerase β), previously considered exclusively a nuclear BER enzyme, was found to localize to mitochondria and play a significant role in mitochondrial base excision repair (BER), mtDNA integrity, and mitochondrial function.","method":"Subcellular fractionation and functional studies in mitochondria (as reviewed/summarized from two independent groups' experimental reports)","journal":"DNA repair","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — commentary summarizing two independent groups' direct localization and functional experiments; replication across labs increases confidence but primary data not directly in this abstract","pmids":["29129598"],"is_preprint":false},{"year":2021,"finding":"The Pol β-Y265C protein, which has low catalytic activity and fidelity and is deficient in microhomology-mediated end-joining, causes accumulation of BER intermediates leading to cell death; deletion of upstream DNA glycosylases OGG1 and NEIL1 in PolbY265C mice reduced BER intermediate accumulation and decreased severity of renal disease in lupus, placing POLB downstream of these glycosylases in the BER pathway.","method":"Genetic epistasis using double-knockout mice (PolbY265C/+ crossed with Ogg1 and Neil1 knockouts); measurement of antinuclear antibodies and renal disease severity","journal":"DNA repair","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis in mouse model with defined cellular pathway placement; single lab with multiple phenotypic readouts","pmids":["34186496"],"is_preprint":false},{"year":2022,"finding":"Bone marrow transplantation from PolbY265C/C mice into wild-type recipients recapitulates lupus-like disease (antinuclear antibodies and renal disease), demonstrating that the hematopoietic compartment is sufficient for lupus development caused by the POLB-Y265C mutation.","method":"Bone marrow transplantation (hematopoietic chimera); measurement of antinuclear antibodies and renal pathology in recipient mice","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean in vivo genetic experiment with cell-type specificity established; single lab, two orthogonal readouts (serology and histopathology)","pmids":["35486639"],"is_preprint":false},{"year":2025,"finding":"CRISPR screen identified POLB as a synthetic lethal enhancer of PARP inhibition specifically in BRCA1/2-mutated cancer cells; both the polymerase and lyase catalytic activities of POLB are required for this synergistic lethality, as demonstrated by overexpression of catalytically inactive mutants. POLB KO combined with PARPi increased single- and double-strand DNA breaks, cell-cycle arrest, and apoptosis, and produced profound tumor regression in BRCA1-mutant and BRCA2-null xenograft models.","method":"CRISPR knockout screen; POLB KO and catalytically inactive mutant overexpression in isogenic BRCA1/2-mutant vs. wild-type cell lines; DNA damage marker quantification; murine xenograft models with niraparib treatment","journal":"Molecular cancer therapeutics","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (CRISPR screen, mutagenesis of catalytic residues, isogenic cell lines, in vivo xenograft) across both in vitro and in vivo systems establishing mechanism","pmids":["40326293"],"is_preprint":false},{"year":2024,"finding":"POLB possesses dual enzymatic activities — a lyase activity (dRP lyase) and a polymerase (gap-filling) activity — both of which can be independently measured and are both required for the synthetic lethal interaction with PARP inhibitors in BRCA-mutant cells, as confirmed by SAMDI mass spectrometry-based duplexed assay and fluorescence strand-displacement assay.","method":"High-throughput SAMDI mass spectrometry duplexed enzymatic assay measuring lyase and polymerase activities separately; fluorescence-based polymerase strand-displacement assay; affinity selection mass spectrometry binding assay","journal":"SLAS technology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro biochemical reconstitution of dual enzymatic activities with multiple orthogonal assay formats; single lab","pmids":["39094983"],"is_preprint":false},{"year":2024,"finding":"Overexpression of POLB in bovine primary myocytes promotes apoptosis, associated with increased CASP9 gene expression, while POLB knockdown had no significant effect on cell viability, indicating a pro-apoptotic function for POLB overexpression linked to the intrinsic apoptosis pathway.","method":"POLB overexpression and siRNA knockdown in bovine primary myocytes; apoptosis assays; quantitative gene expression of apoptotic markers including CASP9","journal":"Animals","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, single model system (bovine myocytes), limited mechanistic follow-up; no orthogonal validation","pmids":["38731327"],"is_preprint":false}],"current_model":"Human POLB encodes DNA polymerase β (pol β), a bifunctional enzyme with dRP lyase and gap-filling polymerase activities that is the primary polymerase in the base excision repair (BER) pathway; it acts downstream of DNA glycosylases (OGG1, NEIL1) to process BER intermediates, localizes to both the nucleus and mitochondria, and its catalytic activities in BER and microhomology-mediated end-joining are required for proper immune repertoire generation (with deficiency causing lupus-like disease in the hematopoietic compartment) and for a synthetic lethal interaction with PARP inhibitors in BRCA1/2-mutant cancers."},"narrative":{"mechanistic_narrative":"POLB encodes DNA polymerase β (pol β), a bifunctional enzyme central to base excision repair (BER) that carries two independently measurable catalytic activities — a dRP lyase activity and a gap-filling polymerase activity [PMID:39094983]. It acts downstream of the DNA glycosylases OGG1 and NEIL1 to process BER intermediates, and genetic epistasis places loss of pol β activity as the cause of toxic intermediate accumulation that these glycosylases initiate [PMID:34186496]. Loss-of-function POLB variants reduce polymerase activity and fail to rescue cells from alkylation (MMS) cytotoxicity, compromising BER and promoting genomic instability [PMID:22577134]. In vivo, a hypomorphic slow-activity allele (Y265C) produces aberrant immune repertoire generation — shortened immunoglobulin heavy-chain junctions and elevated somatic hypermutation — and drives lupus-like autoimmune disease, an effect that is intrinsic to the hematopoietic compartment [PMID:24388753, PMID:35486639]. Beyond its canonical nuclear role, pol β also localizes to mitochondria and contributes to mitochondrial BER and mtDNA integrity [PMID:29129598]. Both the polymerase and lyase activities are required for a synthetic lethal interaction with PARP inhibition specifically in BRCA1/2-mutant cancer cells, where POLB loss combined with PARPi increases DNA breaks and apoptosis and drives tumor regression [PMID:40326293, PMID:39094983].","teleology":[{"year":2012,"claim":"Established that naturally occurring POLB mutations are functionally deleterious, linking reduced pol β polymerase activity to impaired BER and cancer-associated genomic instability.","evidence":"In vitro polymerase activity assays of colorectal tumor-derived POLB variants plus MMS cytotoxicity rescue in pol β-deficient cells","pmids":["22577134"],"confidence":"Medium","gaps":["Causal contribution of these variants to tumor initiation in vivo not demonstrated","Effect on dRP lyase activity not separately measured"]},{"year":2014,"claim":"Connected pol β catalytic activity during immune diversification to organismal disease, showing that a slow-activity allele drives autoimmunity via aberrant BER intermediates during immunoglobulin processing.","evidence":"Knock-in POLB-Y265C hypomorphic mouse with immunology, pathology, and Ig junction/somatic hypermutation readouts","pmids":["24388753"],"confidence":"High","gaps":["Molecular identity of the toxic BER intermediates not directly characterized","Cell type driving autoimmunity not yet localized at this stage"]},{"year":2017,"claim":"Extended pol β's functional compartment beyond the nucleus by demonstrating mitochondrial localization and a role in mitochondrial BER and mtDNA integrity.","evidence":"Subcellular fractionation and functional mitochondrial studies summarized from two independent groups","pmids":["29129598"],"confidence":"Medium","gaps":["Import mechanism into mitochondria not defined","Relative contribution of nuclear vs. mitochondrial pol β to phenotypes unresolved"]},{"year":2021,"claim":"Ordered pol β within the BER pathway by genetic epistasis, placing it downstream of OGG1 and NEIL1 and showing that removing upstream glycosylases relieves toxic intermediate accumulation.","evidence":"Double-knockout mice (PolbY265C crossed with Ogg1 and Neil1 KOs) with antinuclear antibody and renal disease readouts","pmids":["34186496"],"confidence":"Medium","gaps":["Microhomology-mediated end-joining defect mechanism not biochemically dissected","Whether other glycosylases contribute remains untested"]},{"year":2022,"claim":"Localized the disease-driving cell compartment by showing the hematopoietic system is sufficient to transfer pol β-deficiency lupus.","evidence":"Bone marrow transplantation from PolbY265C/C mice into wild-type recipients with serology and histopathology","pmids":["35486639"],"confidence":"Medium","gaps":["Specific hematopoietic lineage responsible not pinpointed","Whether non-hematopoietic pol β modifies disease not addressed"]},{"year":2024,"claim":"Biochemically resolved pol β's two catalytic activities into independently measurable lyase and polymerase functions, enabling activity-specific dissection.","evidence":"SAMDI mass spectrometry duplexed enzymatic assay, fluorescence strand-displacement assay, and affinity-selection MS binding assay","pmids":["39094983"],"confidence":"Medium","gaps":["Single-lab assay development without independent confirmation","Coordination between the two activities in vivo not addressed"]},{"year":2024,"claim":"Reported a pro-apoptotic effect of POLB overexpression linked to the intrinsic apoptosis pathway in a non-canonical model system.","evidence":"POLB overexpression and siRNA knockdown in bovine primary myocytes with apoptosis assays and CASP9 expression","pmids":["38731327"],"confidence":"Low","gaps":["Single lab, single bovine myocyte system without orthogonal validation","Mechanistic link between pol β and CASP9 induction undefined","Relevance to human pol β biology unestablished"]},{"year":2025,"claim":"Defined a therapeutically actionable vulnerability by showing pol β is synthetic lethal with PARP inhibition in BRCA1/2-mutant cancers and that both catalytic activities are required.","evidence":"CRISPR KO screen, catalytically inactive mutant overexpression in isogenic BRCA1/2 cell lines, DNA damage quantification, and niraparib xenograft models","pmids":["40326293"],"confidence":"High","gaps":["Precise molecular basis of the BRCA-specific dependence not fully mapped","Resistance mechanisms and clinical translatability untested"]},{"year":null,"claim":"How pol β's nuclear and mitochondrial BER functions are coordinated, and how its dual catalytic activities are mechanistically partitioned across immune repertoire generation, autoimmunity, and the BRCA synthetic lethal context, remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model linking dual activities to substrate handoff in the timeline","Mitochondrial import and regulation uncharacterized","Direct molecular partners in BER complexes not defined in the corpus"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140097","term_label":"catalytic activity, acting on DNA","supporting_discovery_ids":[0,5,6]},{"term_id":"GO:0016829","term_label":"lyase activity","supporting_discovery_ids":[6,5]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[2]}],"pathway":[{"term_id":"R-HSA-73894","term_label":"DNA Repair","supporting_discovery_ids":[0,3,5]}],"complexes":[],"partners":[],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P06746","full_name":"DNA polymerase beta","aliases":["5'-deoxyribose-phosphate lyase","5'-dRP lyase","AP lyase"],"length_aa":335,"mass_kda":38.2,"function":"Repair polymerase that plays a key role in base-excision repair (PubMed:10556592, PubMed:9207062, PubMed:9572863). During this process, the damaged base is excised by specific DNA glycosylases, the DNA backbone is nicked at the abasic site by an apurinic/apyrimidic (AP) endonuclease, and POLB removes 5'-deoxyribose-phosphate from the preincised AP site acting as a 5'-deoxyribose-phosphate lyase (5'-dRP lyase); through its DNA polymerase activity, it adds one nucleotide to the 3' end of the arising single-nucleotide gap (PubMed:10556592, PubMed:17526740, PubMed:9556598, PubMed:9572863, PubMed:9614142). Conducts 'gap-filling' DNA synthesis in a stepwise distributive fashion rather than in a processive fashion as for other DNA polymerases. It is also able to cleave sugar-phosphate bonds 3' to an intact AP site, acting as an AP lyase (PubMed:9614142)","subcellular_location":"Nucleus; Cytoplasm","url":"https://www.uniprot.org/uniprotkb/P06746/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/POLB","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"CALM3","stoichiometry":0.2},{"gene":"HIST2H2BE","stoichiometry":0.2},{"gene":"HMGA1","stoichiometry":0.2},{"gene":"HMGN5","stoichiometry":0.2},{"gene":"NUCKS1","stoichiometry":0.2},{"gene":"NUMA1","stoichiometry":0.2},{"gene":"PARP1","stoichiometry":0.2},{"gene":"SSRP1","stoichiometry":0.2},{"gene":"TDP1","stoichiometry":0.2},{"gene":"TOP1","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/POLB","total_profiled":1310},"omim":[{"mim_id":"613692","title":"TERMINAL URIDYLYL TRANSFERASE 4; TUT4","url":"https://www.omim.org/entry/613692"},{"mim_id":"612823","title":"TATA BOX-BINDING PROTEIN-ASSOCIATED FACTOR 1D; TAF1D","url":"https://www.omim.org/entry/612823"},{"mim_id":"608274","title":"PROTEIN ARGININE METHYLTRANSFERASE 6; PRMT6","url":"https://www.omim.org/entry/608274"},{"mim_id":"607207","title":"STIP1 HOMOLOGOUS AND U BOX-CONTAINING PROTEIN 1; STUB1","url":"https://www.omim.org/entry/607207"},{"mim_id":"606350","title":"APRATAXIN; APTX","url":"https://www.omim.org/entry/606350"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Vesicles","reliability":"Supported"},{"location":"Cytosol","reliability":"Supported"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in all","driving_tissues":[{"tissue":"brain","ntpm":176.1}],"url":"https://www.proteinatlas.org/search/POLB"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P06746","domains":[{"cath_id":"1.10.150.110","chopping":"9-90","consensus_level":"medium","plddt":93.7917,"start":9,"end":90},{"cath_id":"1.10.150.20","chopping":"92-147","consensus_level":"medium","plddt":97.1737,"start":92,"end":147},{"cath_id":"3.30.460.10","chopping":"149-260","consensus_level":"high","plddt":96.3037,"start":149,"end":260},{"cath_id":"3.30.210.10","chopping":"274-331","consensus_level":"high","plddt":95.9345,"start":274,"end":331}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P06746","model_url":"https://alphafold.ebi.ac.uk/files/AF-P06746-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P06746-F1-predicted_aligned_error_v6.png","plddt_mean":94.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POLB","jax_strain_url":"https://www.jax.org/strain/search?query=POLB"},"sequence":{"accession":"P06746","fasta_url":"https://rest.uniprot.org/uniprotkb/P06746.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P06746/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P06746"}},"corpus_meta":[{"pmid":"10217781","id":"PMC_10217781","title":"DNA polymerase II (polB) is involved in a new DNA repair pathway for DNA interstrand cross-links in Escherichia coli.","date":"1999","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/10217781","citation_count":100,"is_preprint":false},{"pmid":"22577134","id":"PMC_22577134","title":"Human POLB gene is mutated in high percentage of colorectal tumors.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22577134","citation_count":88,"is_preprint":false},{"pmid":"2228959","id":"PMC_2228959","title":"The Escherichia coli polB gene, which encodes DNA polymerase II, is regulated by the SOS system.","date":"1990","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/2228959","citation_count":85,"is_preprint":false},{"pmid":"1577702","id":"PMC_1577702","title":"Isolation of DNA damage-inducible promoters in Escherichia coli: regulation of polB (dinA), dinG, and dinH by LexA repressor.","date":"1992","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/1577702","citation_count":78,"is_preprint":false},{"pmid":"9079692","id":"PMC_9079692","title":"The Escherichia coli polB locus is identical to dinA, the structural gene for DNA polymerase II. Characterization of Pol II purified from a polB mutant.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9079692","citation_count":62,"is_preprint":false},{"pmid":"24388753","id":"PMC_24388753","title":"Mutation of POLB causes lupus in mice.","date":"2014","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/24388753","citation_count":49,"is_preprint":false},{"pmid":"29129598","id":"PMC_29129598","title":"POLB: A new role of DNA polymerase beta in mitochondrial base excision repair.","date":"2017","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/29129598","citation_count":34,"is_preprint":false},{"pmid":"1706959","id":"PMC_1706959","title":"Recurrent homogeneously staining regions in 8p1 in breast cancer and lack of amplification of POLB, LHRH, and PLAT genes.","date":"1991","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/1706959","citation_count":29,"is_preprint":false},{"pmid":"9078303","id":"PMC_9078303","title":"Mutation analysis of 8p genes POLB and PPP2CB in bladder cancer.","date":"1997","source":"Cancer genetics and cytogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/9078303","citation_count":27,"is_preprint":false},{"pmid":"2684981","id":"PMC_2684981","title":"Cloning the polB gene of Escherichia coli and identification of its product.","date":"1989","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2684981","citation_count":24,"is_preprint":false},{"pmid":"7592365","id":"PMC_7592365","title":"Functional recA, lexA, umuD, umuC, polA, and polB genes are not required for the Escherichia coli UVM response.","date":"1995","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/7592365","citation_count":23,"is_preprint":false},{"pmid":"25561897","id":"PMC_25561897","title":"Clinical significance of a point mutation in DNA polymerase beta (POLB) gene in gastric cancer.","date":"2015","source":"International journal of biological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/25561897","citation_count":21,"is_preprint":false},{"pmid":"19167932","id":"PMC_19167932","title":"Population-specific variation in haplotype composition and heterozygosity at the POLB locus.","date":"2009","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/19167932","citation_count":19,"is_preprint":false},{"pmid":"2261080","id":"PMC_2261080","title":"Nucleotide sequence and deletion analysis of the polB gene of Escherichia coli.","date":"1990","source":"DNA and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/2261080","citation_count":18,"is_preprint":false},{"pmid":"21283796","id":"PMC_21283796","title":"In vivo characterization of the homing endonuclease within the polB gene in the halophilic archaeon Haloferax volcanii.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21283796","citation_count":18,"is_preprint":false},{"pmid":"27109703","id":"PMC_27109703","title":"Secondary Interaction Interfaces with PCNA Control Conformational Switching of DNA Polymerase PolB from Polymerization to Editing.","date":"2016","source":"The journal of physical chemistry. B","url":"https://pubmed.ncbi.nlm.nih.gov/27109703","citation_count":16,"is_preprint":false},{"pmid":"19896487","id":"PMC_19896487","title":"Genetic insertions and diversification of the PolB-type DNA polymerase (gp43) of T4-related phages.","date":"2009","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19896487","citation_count":14,"is_preprint":false},{"pmid":"15365817","id":"PMC_15365817","title":"Molecular evolution of a mitochondrial polB gene, encoding a family B DNA polymerase, towards the elimination from Agrocybe mitochondrial genomes.","date":"2004","source":"Molecular genetics and genomics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/15365817","citation_count":14,"is_preprint":false},{"pmid":"10323231","id":"PMC_10323231","title":"Molecular cloning, sequence and expression of Aa-polB, a mitochondrial gene encoding a family B DNA polymerase from the edible basidiomycete Agrocybe aegerita.","date":"1999","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/10323231","citation_count":13,"is_preprint":false},{"pmid":"3009375","id":"PMC_3009375","title":"Assignment of the gene for human DNA polymerase beta (POLB) to chromosome 8.","date":"1986","source":"Japanese journal of cancer research : Gann","url":"https://pubmed.ncbi.nlm.nih.gov/3009375","citation_count":13,"is_preprint":false},{"pmid":"27471563","id":"PMC_27471563","title":"A Point Mutation in DNA Polymerase β (POLB) Gene Is Associated with Increased Progesterone Receptor (PR) Expression and Intraperitoneal Metastasis in Gastric Cancer.","date":"2016","source":"Journal of Cancer","url":"https://pubmed.ncbi.nlm.nih.gov/27471563","citation_count":11,"is_preprint":false},{"pmid":"11282628","id":"PMC_11282628","title":"Duplication of a truncated paralog of the family B DNA polymerase gene Aa-polB in the Agrocybe aegerita mitochondrial genome.","date":"2001","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/11282628","citation_count":8,"is_preprint":false},{"pmid":"25156741","id":"PMC_25156741","title":"Involvement of stress-related genes polB and PA14_46880 in biofilm formation of Pseudomonas aeruginosa.","date":"2014","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/25156741","citation_count":8,"is_preprint":false},{"pmid":"26167925","id":"PMC_26167925","title":"Genetic Variants of IκB Kinase β (IKBKB) and Polymerase β (POLB) Were Not Associated with Systemic Lupus Erythematosus Risk in a Chinese Han Population.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26167925","citation_count":7,"is_preprint":false},{"pmid":"34186496","id":"PMC_34186496","title":"DNA glycosylase deficiency leads to decreased severity of lupus in the Polb-Y265C mouse model.","date":"2021","source":"DNA repair","url":"https://pubmed.ncbi.nlm.nih.gov/34186496","citation_count":6,"is_preprint":false},{"pmid":"32822531","id":"PMC_32822531","title":"Protein Splicing Activity of the Haloferax volcanii PolB-c Intein Is Sensitive to Homing Endonuclease Domain Mutations.","date":"2020","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32822531","citation_count":6,"is_preprint":false},{"pmid":"25420601","id":"PMC_25420601","title":"Synergistic template-free synthesis of dsDNA by Thermococcus nautili primase PolpTN2, DNA polymerase PolB, and pTN2 helicase.","date":"2014","source":"Extremophiles : life under extreme conditions","url":"https://pubmed.ncbi.nlm.nih.gov/25420601","citation_count":6,"is_preprint":false},{"pmid":"27569236","id":"PMC_27569236","title":"Association Study of a Proliferation-inducing Ligand, Spermatogenesis Associated 8, Platelet-derived Growth Factor Receptor-alpha, and POLB Polymorphisms with Systemic Lupus Erythematosus in Chinese Han Population.","date":"2016","source":"Chinese medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/27569236","citation_count":6,"is_preprint":false},{"pmid":"35128818","id":"PMC_35128818","title":"Polymorphic mutations in the polb gene promoter and their impact on transcriptional activity.","date":"2022","source":"Thoracic cancer","url":"https://pubmed.ncbi.nlm.nih.gov/35128818","citation_count":3,"is_preprint":false},{"pmid":"40326293","id":"PMC_40326293","title":"CRISPR Screens Identify POLB as a Synthetic Lethal Enhancer of PARP Inhibition Exclusively in BRCA-Mutated Tumors.","date":"2025","source":"Molecular cancer therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/40326293","citation_count":3,"is_preprint":false},{"pmid":"39094983","id":"PMC_39094983","title":"A duplexed high-throughput mass spectrometry assay for bifunctional POLB polymerase and lyase activity.","date":"2024","source":"SLAS technology","url":"https://pubmed.ncbi.nlm.nih.gov/39094983","citation_count":3,"is_preprint":false},{"pmid":"38691429","id":"PMC_38691429","title":"Analysis of Cancer-Associated Mutations of POLB Using Machine Learning and Bioinformatics.","date":"2024","source":"IEEE/ACM transactions on computational biology and bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/38691429","citation_count":3,"is_preprint":false},{"pmid":"35486639","id":"PMC_35486639","title":"The hematopoietic compartment is sufficient for lupus development resulting from the POLB-Y265C mutation.","date":"2022","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/35486639","citation_count":1,"is_preprint":false},{"pmid":"33276123","id":"PMC_33276123","title":"DNA alternate polymerase PolB mediates inhibition of type III secretion in Pseudomonas aeruginosa.","date":"2020","source":"Microbes and infection","url":"https://pubmed.ncbi.nlm.nih.gov/33276123","citation_count":1,"is_preprint":false},{"pmid":"38731327","id":"PMC_38731327","title":"POLB Regulates Proliferation and Apoptosis of Bovine Primary Myocytes.","date":"2024","source":"Animals : an open access journal from MDPI","url":"https://pubmed.ncbi.nlm.nih.gov/38731327","citation_count":0,"is_preprint":false},{"pmid":"41427953","id":"PMC_41427953","title":"Endogenized polinton-like viruses in the dinoflagellate Oxyrrhis marina uncover novel PolB fusion.","date":"2025","source":"The Journal of general virology","url":"https://pubmed.ncbi.nlm.nih.gov/41427953","citation_count":0,"is_preprint":false},{"pmid":"41660627","id":"PMC_41660627","title":"POLB 001, a p38 MAPK inhibitor, decreases local and systemic inflammatory responses following in vivo LPS administration in healthy volunteers: a randomised, double-blind, placebo-controlled study.","date":"2026","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/41660627","citation_count":0,"is_preprint":false},{"pmid":"6754528","id":"PMC_6754528","title":"[Effect of polB mutation on the nature of the thymineless death of thy- cells of Escherichia coli K-12].","date":"1982","source":"Genetika","url":"https://pubmed.ncbi.nlm.nih.gov/6754528","citation_count":0,"is_preprint":false},{"pmid":"41505470","id":"PMC_41505470","title":"Genomic profiling of active vitamin D colonic responses in African- and European-Americans identifies an ancestry-related regulatory variant of POLB.","date":"2026","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/41505470","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.04.09.647365","title":"Genomic profiling of active vitamin D colonic responses in African- and European-Americans identifies an ancestry-related regulatory variant of  <i>POLB</i>","date":"2025-04-09","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.09.647365","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.01.22.633263","title":"Hybrid sequencing reveals the genome of a  <i>Chrysochromulina parva</i>  virus and highlight its distinct replication strategy","date":"2025-01-24","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.22.633263","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":19536,"output_tokens":2464,"usd":0.047784,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":9264,"output_tokens":2880,"usd":0.05916,"stage2_stop_reason":"end_turn"},"total_usd":0.106944,"stage1_batch_id":"msgbatch_01CNoDbkChHEkgrJnL7BwtGJ","stage2_batch_id":"msgbatch_016Y4x9E9Wg5VQDANj9quSQD","note":"batch pricing = 50% of standard"},"stage1_raw":"Looking at the corpus, I need to identify papers about the human/mammalian POLB gene (DNA polymerase beta, involved in base excision repair) versus papers about the bacterial E. coli polB gene (DNA polymerase II), archaeal polB, phage polB, fungal polB, Pseudomonas polB, or other symbol collisions.\n\nThe human gene POLB encodes DNA polymerase β (pol β), a key BER enzyme. Papers about E. coli DNA polymerase II (polB/dinA) are about a different protein (family B polymerase vs. family X). These are NOT orthologs of human POLB - E. coli pol II is a family B polymerase while human pol β is a family X polymerase. I will exclude E. coli polB papers as symbol collisions.\n\nPapers about archaeal PolB, fungal polB, phage polB, Pseudomonas polB are also different proteins. The \"POLB 001\" paper (PMID:41660627) is about a p38 MAPK inhibitor drug, not the gene.\n\nRelevant papers about human POLB (DNA polymerase β): PMIDs 22577134, 24388753, 29129598, 34186496, 40326293, 39094983, 35486639, 38731327.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2012,\n      \"finding\": \"POLB variants found in 40% of colorectal tumors show reduced polymerase activity in vitro and fail to fully rescue POLB-deficient cells from methylmethane sulfonate (MMS)-induced cytotoxicity, demonstrating that loss-of-function POLB mutations compromise base excision repair (BER) and may drive genomic instability.\",\n      \"method\": \"In vitro polymerase activity assays of tumor-derived POLB variants; MMS cytotoxicity rescue assay in pol β-deficient cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro enzymatic activity assays plus cell-based rescue experiments in a single lab with two orthogonal methods\",\n      \"pmids\": [\"22577134\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Mice expressing a hypomorphic POLB allele encoding a slow-activity pol β (Y265C) develop lupus-like autoimmune disease with shorter immunoglobulin heavy-chain junctions and dramatically increased somatic hypermutation, establishing that decreased pol β catalytic activity during generation of immune diversity leads to aberrant BER intermediates that drive autoimmunity.\",\n      \"method\": \"Knock-in mouse model expressing hypomorphic POLB-Y265C allele; analysis of antinuclear antibodies, glomerulonephritis, immunoglobulin junction lengths, and somatic hypermutation rates\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — in vivo genetic mouse model with multiple orthogonal phenotypic readouts (immunology, pathology, molecular) establishing mechanistic link between pol β activity and immune repertoire generation\",\n      \"pmids\": [\"24388753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"POLB (DNA polymerase β), previously considered exclusively a nuclear BER enzyme, was found to localize to mitochondria and play a significant role in mitochondrial base excision repair (BER), mtDNA integrity, and mitochondrial function.\",\n      \"method\": \"Subcellular fractionation and functional studies in mitochondria (as reviewed/summarized from two independent groups' experimental reports)\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — commentary summarizing two independent groups' direct localization and functional experiments; replication across labs increases confidence but primary data not directly in this abstract\",\n      \"pmids\": [\"29129598\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"The Pol β-Y265C protein, which has low catalytic activity and fidelity and is deficient in microhomology-mediated end-joining, causes accumulation of BER intermediates leading to cell death; deletion of upstream DNA glycosylases OGG1 and NEIL1 in PolbY265C mice reduced BER intermediate accumulation and decreased severity of renal disease in lupus, placing POLB downstream of these glycosylases in the BER pathway.\",\n      \"method\": \"Genetic epistasis using double-knockout mice (PolbY265C/+ crossed with Ogg1 and Neil1 knockouts); measurement of antinuclear antibodies and renal disease severity\",\n      \"journal\": \"DNA repair\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis in mouse model with defined cellular pathway placement; single lab with multiple phenotypic readouts\",\n      \"pmids\": [\"34186496\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Bone marrow transplantation from PolbY265C/C mice into wild-type recipients recapitulates lupus-like disease (antinuclear antibodies and renal disease), demonstrating that the hematopoietic compartment is sufficient for lupus development caused by the POLB-Y265C mutation.\",\n      \"method\": \"Bone marrow transplantation (hematopoietic chimera); measurement of antinuclear antibodies and renal pathology in recipient mice\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean in vivo genetic experiment with cell-type specificity established; single lab, two orthogonal readouts (serology and histopathology)\",\n      \"pmids\": [\"35486639\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CRISPR screen identified POLB as a synthetic lethal enhancer of PARP inhibition specifically in BRCA1/2-mutated cancer cells; both the polymerase and lyase catalytic activities of POLB are required for this synergistic lethality, as demonstrated by overexpression of catalytically inactive mutants. POLB KO combined with PARPi increased single- and double-strand DNA breaks, cell-cycle arrest, and apoptosis, and produced profound tumor regression in BRCA1-mutant and BRCA2-null xenograft models.\",\n      \"method\": \"CRISPR knockout screen; POLB KO and catalytically inactive mutant overexpression in isogenic BRCA1/2-mutant vs. wild-type cell lines; DNA damage marker quantification; murine xenograft models with niraparib treatment\",\n      \"journal\": \"Molecular cancer therapeutics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (CRISPR screen, mutagenesis of catalytic residues, isogenic cell lines, in vivo xenograft) across both in vitro and in vivo systems establishing mechanism\",\n      \"pmids\": [\"40326293\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"POLB possesses dual enzymatic activities — a lyase activity (dRP lyase) and a polymerase (gap-filling) activity — both of which can be independently measured and are both required for the synthetic lethal interaction with PARP inhibitors in BRCA-mutant cells, as confirmed by SAMDI mass spectrometry-based duplexed assay and fluorescence strand-displacement assay.\",\n      \"method\": \"High-throughput SAMDI mass spectrometry duplexed enzymatic assay measuring lyase and polymerase activities separately; fluorescence-based polymerase strand-displacement assay; affinity selection mass spectrometry binding assay\",\n      \"journal\": \"SLAS technology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro biochemical reconstitution of dual enzymatic activities with multiple orthogonal assay formats; single lab\",\n      \"pmids\": [\"39094983\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Overexpression of POLB in bovine primary myocytes promotes apoptosis, associated with increased CASP9 gene expression, while POLB knockdown had no significant effect on cell viability, indicating a pro-apoptotic function for POLB overexpression linked to the intrinsic apoptosis pathway.\",\n      \"method\": \"POLB overexpression and siRNA knockdown in bovine primary myocytes; apoptosis assays; quantitative gene expression of apoptotic markers including CASP9\",\n      \"journal\": \"Animals\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, single model system (bovine myocytes), limited mechanistic follow-up; no orthogonal validation\",\n      \"pmids\": [\"38731327\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"Human POLB encodes DNA polymerase β (pol β), a bifunctional enzyme with dRP lyase and gap-filling polymerase activities that is the primary polymerase in the base excision repair (BER) pathway; it acts downstream of DNA glycosylases (OGG1, NEIL1) to process BER intermediates, localizes to both the nucleus and mitochondria, and its catalytic activities in BER and microhomology-mediated end-joining are required for proper immune repertoire generation (with deficiency causing lupus-like disease in the hematopoietic compartment) and for a synthetic lethal interaction with PARP inhibitors in BRCA1/2-mutant cancers.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"POLB encodes DNA polymerase β (pol β), a bifunctional enzyme central to base excision repair (BER) that carries two independently measurable catalytic activities — a dRP lyase activity and a gap-filling polymerase activity [#6]. It acts downstream of the DNA glycosylases OGG1 and NEIL1 to process BER intermediates, and genetic epistasis places loss of pol β activity as the cause of toxic intermediate accumulation that these glycosylases initiate [#3]. Loss-of-function POLB variants reduce polymerase activity and fail to rescue cells from alkylation (MMS) cytotoxicity, compromising BER and promoting genomic instability [#0]. In vivo, a hypomorphic slow-activity allele (Y265C) produces aberrant immune repertoire generation — shortened immunoglobulin heavy-chain junctions and elevated somatic hypermutation — and drives lupus-like autoimmune disease, an effect that is intrinsic to the hematopoietic compartment [#1, #4]. Beyond its canonical nuclear role, pol β also localizes to mitochondria and contributes to mitochondrial BER and mtDNA integrity [#2]. Both the polymerase and lyase activities are required for a synthetic lethal interaction with PARP inhibition specifically in BRCA1/2-mutant cancer cells, where POLB loss combined with PARPi increases DNA breaks and apoptosis and drives tumor regression [#5, #6].\",\n  \"teleology\": [\n    {\n      \"year\": 2012,\n      \"claim\": \"Established that naturally occurring POLB mutations are functionally deleterious, linking reduced pol β polymerase activity to impaired BER and cancer-associated genomic instability.\",\n      \"evidence\": \"In vitro polymerase activity assays of colorectal tumor-derived POLB variants plus MMS cytotoxicity rescue in pol β-deficient cells\",\n      \"pmids\": [\"22577134\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Causal contribution of these variants to tumor initiation in vivo not demonstrated\", \"Effect on dRP lyase activity not separately measured\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Connected pol β catalytic activity during immune diversification to organismal disease, showing that a slow-activity allele drives autoimmunity via aberrant BER intermediates during immunoglobulin processing.\",\n      \"evidence\": \"Knock-in POLB-Y265C hypomorphic mouse with immunology, pathology, and Ig junction/somatic hypermutation readouts\",\n      \"pmids\": [\"24388753\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Molecular identity of the toxic BER intermediates not directly characterized\", \"Cell type driving autoimmunity not yet localized at this stage\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Extended pol β's functional compartment beyond the nucleus by demonstrating mitochondrial localization and a role in mitochondrial BER and mtDNA integrity.\",\n      \"evidence\": \"Subcellular fractionation and functional mitochondrial studies summarized from two independent groups\",\n      \"pmids\": [\"29129598\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Import mechanism into mitochondria not defined\", \"Relative contribution of nuclear vs. mitochondrial pol β to phenotypes unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Ordered pol β within the BER pathway by genetic epistasis, placing it downstream of OGG1 and NEIL1 and showing that removing upstream glycosylases relieves toxic intermediate accumulation.\",\n      \"evidence\": \"Double-knockout mice (PolbY265C crossed with Ogg1 and Neil1 KOs) with antinuclear antibody and renal disease readouts\",\n      \"pmids\": [\"34186496\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Microhomology-mediated end-joining defect mechanism not biochemically dissected\", \"Whether other glycosylases contribute remains untested\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Localized the disease-driving cell compartment by showing the hematopoietic system is sufficient to transfer pol β-deficiency lupus.\",\n      \"evidence\": \"Bone marrow transplantation from PolbY265C/C mice into wild-type recipients with serology and histopathology\",\n      \"pmids\": [\"35486639\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Specific hematopoietic lineage responsible not pinpointed\", \"Whether non-hematopoietic pol β modifies disease not addressed\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Biochemically resolved pol β's two catalytic activities into independently measurable lyase and polymerase functions, enabling activity-specific dissection.\",\n      \"evidence\": \"SAMDI mass spectrometry duplexed enzymatic assay, fluorescence strand-displacement assay, and affinity-selection MS binding assay\",\n      \"pmids\": [\"39094983\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Single-lab assay development without independent confirmation\", \"Coordination between the two activities in vivo not addressed\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Reported a pro-apoptotic effect of POLB overexpression linked to the intrinsic apoptosis pathway in a non-canonical model system.\",\n      \"evidence\": \"POLB overexpression and siRNA knockdown in bovine primary myocytes with apoptosis assays and CASP9 expression\",\n      \"pmids\": [\"38731327\"],\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Single lab, single bovine myocyte system without orthogonal validation\", \"Mechanistic link between pol β and CASP9 induction undefined\", \"Relevance to human pol β biology unestablished\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Defined a therapeutically actionable vulnerability by showing pol β is synthetic lethal with PARP inhibition in BRCA1/2-mutant cancers and that both catalytic activities are required.\",\n      \"evidence\": \"CRISPR KO screen, catalytically inactive mutant overexpression in isogenic BRCA1/2 cell lines, DNA damage quantification, and niraparib xenograft models\",\n      \"pmids\": [\"40326293\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Precise molecular basis of the BRCA-specific dependence not fully mapped\", \"Resistance mechanisms and clinical translatability untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How pol β's nuclear and mitochondrial BER functions are coordinated, and how its dual catalytic activities are mechanistically partitioned across immune repertoire generation, autoimmunity, and the BRCA synthetic lethal context, remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"No structural model linking dual activities to substrate handoff in the timeline\", \"Mitochondrial import and regulation uncharacterized\", \"Direct molecular partners in BER complexes not defined in the corpus\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140097\", \"supporting_discovery_ids\": [0, 5, 6]},\n      {\"term_id\": \"GO:0016829\", \"supporting_discovery_ids\": [6, 5]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-73894\", \"supporting_discovery_ids\": [0, 3, 5]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":6,"faith_pct":83.33333333333333}}